The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

CHRISTINA Park had struggled with yo-yo dieting for years – trapped in a vicious cycle of losing 4 to 8lb, then putting on 6 ...

A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...

For these reasons, people are taking to “microdosing” weight-loss drugs, or using less than the dose recommended by the ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...